Alan M. Garber, Director of Vertex Pharmaceuticals VRTX, has filed 0 purchases and 2 sales on the open market. The latest trade was on 05/01.

AG

AG

Alan M. Garber

Director

Company

Vertex Pharmaceuticals VRTX

First filing

23/02/23

Trades

15 trades

Buys / sales

0 / 2

12-month net buying

No record

Last trade

05/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
ExelixisEXEL	Open-market sale10b5-1 plan	24/03/21	24/03/25	19,205 sh	$24.01	$461,112.05	−35.0%
ExelixisEXEL	Open-market sale	23/02/21	23/02/23	40,000 sh	$17.49	$699,600	−56.0%